Last reviewed · How we verify
To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
This study aims to evaluate the improvement effect on subjective symptoms of gastritis and adverse events through patient self-assessment results (PRO) by conducting follow-up observations for patients with gastritis at 2 to 4 weeks after administration of Mucotra® SR tablets.
Details
| Lead sponsor | Daewoong Pharmaceutical Co. LTD. |
|---|---|
| Status | COMPLETED |
| Enrolment | 2814 |
| Start date | Thu Mar 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Wed Mar 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Gastritis
Countries
South Korea